July 12, 2017 - Episode 1

FDA Approval in ALL, Priority Reviews in CML and Breast Cancer, and More

Gina Columbus reports on an FDA approval in acute lymphoblastic leukemia, priority reviews in chronic myeloid leukemia and breast cancer, ODAC recommendations in ALL and and acute myeloid leukemia, and a clinical hold on 3 multiple myeloma trials.